Glaxosmithkline Pharmaceuticals Ltd.

GLAXO Share PricePharmaceuticals & Drugs

2,600.8

-21.3 (-0.8%)

As on December 12, 2025

Exchange Scrips: BSE500660NSEGLAXOISININE159A01016

Market Cap43,962 Cr

P/E Ratio 47.5

Dividend Yield 0.21 %

Performance

Market performance

Open2,624
High2,635
Volumes1,70,216
Prev2,600.8
Low2,559
As on2025-12-12

Historical performance

1 Year High3,515.7
3 Year High3,515.7
5 Year High3,515.7
1 Year Low1,921
3 Year Low1,227
5 Year Low1,227

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
43,962
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
47.5
Dividend Yield
Dividend Yield
0.21 %

Investment Returns

1 Year
12.9%
3 Years
95.5%
5 Years
67.7%
10 Years
60.3%

Technicals

IndicatorsValueSignal
5-DMA2,583.94Bullish
10-DMA2,551Bullish
20-DMA2,527.92Bullish
50-DMA2,614.63Bearish
100-DMA2,723.94Bearish
200-DMA2,852.35Bearish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters44444
Foreign Investors44444
Domestic Investors---------------
Public Investors122900123625121881119621119224
Government22332

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 47.5.
  • 3Y Stock Price CAGR of the stock is 24.8.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹13233 Million.
  • The company generated revenue of ₹37492 Million in the previous financial year.

Glaxosmithkline Pharmaceuticals Ltd.

2600.8-21.3   (-0.8%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1141402.6
No. of Shares: 439 (Approx)
Performance:14.1%
P/L: ₹141402.6

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month